Anebulo Pharmaceuticals【ANEB】銘柄情報

Anebulo Pharmaceuticals Inc (ANEB) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

0.43425

( - )

買値

0.40

売値

0.45

出来高

0.00 日の範囲 0.00

0.00 52 週間の範囲 0.00

前日終値

0.43425

始値

時刻

最終取引時間

平均取引量 (3 か月)

財務取引量

VWAP

Form 15-12G - Securities registration termination [Section 12(g)]

Form 25 - Notification of the removal from listing and registration of matured, redeemed or retired securities

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Anebulo Pharmaceuticals Reports Second Quarter Fiscal Year 2026 Financial Results and Recent Updates

Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage pharmaceutical company developing novel solutions for people suffering from acute...

Form 8-K - Current report

Anebulo Pharmaceuticals Announces Intention to Voluntarily Delist from Nasdaq and Deregister with SEC

Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage pharmaceutical company developing novel solutions for people suffering from acute...

Form SC TO-I/A - Tender offer statement by Issuer: [Amend]

Form 8-K - Current report

Anebulo Pharmaceuticals Announces Final Results of Tender Offer

Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage pharmaceutical company developing novel solutions for people suffering from acute...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

ANEB - Frequently Asked Questions (FAQ)

What is the current Anebulo Pharmaceuticals Inc share price?

The current share price of Anebulo Pharmaceuticals Inc is US$ 0.43425

What is the 1 year trading range for Anebulo Pharmaceuticals Inc share price?

Anebulo Pharmaceuticals Inc has traded in the range of US$ 0.00 to US$ 0.00 during the past year

John Doe 2024 2分前

You mean like the 35 million in phantom volume that took place on no news and all the sudden they drop Nexpatch???

XERI

Timing101 4分前

I have been busy on a Larger AG project , but checked in on EZES today . My Goodness folks are truly upset with MG , as expected.
--
There is a posting in Linkedin in the Past 24 hours that MG met with the AFRICA "Customer" PRIOR to shipping with a picture of someone
but no s

EZES

satter 4分前

I agree with what you laid out. I am pretty sure sometime ago, I did post that EM could keep the deposit for some breach of contract. Probable was accuse of being a fear mongler back then.

Has Hiru even disclosed the legal situation ( 6 million dollar Judgment ) to EM? Or is that why

HIRU

juicyjuice10002 6分前

Not necessarily. USA is already on the verge of compromising on IRAN war. To gain the respect of the investment world, the current administration has to prove that USA is not a thief and respects the shareholders, otherwise no one in the right mind will invest in USA. Today was just a taste of what

FNMA

Waterbottle52 6分前

6/30/26 Q2
MDLK should post new revenue
ASA Robotics

MDLK

z-money 7分前

Do we know exactly how many open NNRX cases exist as of today ?
That Dec 2025 settlement was between the parties of the last NNRX acquisition/merger deal that went south super fast.

NNRX

ErnieBilco 8分前

The offering circular>>>>

https://www.sec.gov/Archives/edgar/data/2134397/000187285626000197/AR_FORMCA.pdf

AREB

skitahoe 10分前

Meirluc, the only way the Grade C suite would delay approval is it it's EDEN based and even then, the delay would be the EDEN as the company identified another place that could become a hub. It's not in Sawston, but it's in the UK and that should be all that matters.

If the UK regu

NWBO

Talisman33 10分前

Wouldn’t it be great if they get another government windfall? It can help extend the timing of the next dilution by way of acquiring another “going concern”.

CVSI

rosemountbomber 11分前

Theres no going back ...so after this correction ...catch the wave :--)

I have been raising some cash and readying my buy orders - at the right price.

Not to mention that after booking profits on NOW and CRM a few days ago, I re-entered those at the close today. The AI

UNCY

VapeGod3000 11分前

Same bro. I have shares at $.08…. I’ve been praying for years this comes back lol

ATWT

MadBrewer 12分前

"It converts the paper to get the physical again."
It's by no means a daily play but, a way to trade the volatility on a
weekly, bi-weekly, even monthly basis.

I got a separate tube of ASE's that are marked, "Flips" just for that purpose.
I keep that one separate

BIEI

Dodger1 12分前

You always refer to yourself wen🫢

BTCUSD

TightCoil 13分前

Not a Bad Day At All, esp when you consider
yesterday's action:
FNMA – 6.92 - +57c -3,774,160
FMCC - 6.40 - +71c - 2,187,828
So let's quit moanin' and groanin'
just cause we lost 7 or 8 centavos - Celebrate

FNMA

Doc logic 15分前

brazen22,

One application, with added info for label discussions is still one application and one label discussion based on trial data and Real World Evidence. This MAA is for a treatment method that uses dendritic cells that are by nature tissue agnostic. NWBO may be utilizing a no

NWBO

meirluc 22分前

You may be right that a labeling issue may have been responsible for the approval delay and I may be right that the Grade C suite's upgrading and construction is a reason for that delay. If so, let's hope that both of those bottlenecks will be eliminated within the coming months, followed by an unc

NWBO

Kool Aid Man 25分前

Does today's announcement constitute the required 'disclosure of a material event within 4 days'? If so that eliminates one potential sanction but not the one for failing to disclose Roxanna's recent guilty plea resulting in her 3 year criminal probation.

HIRU

janice shell 26分前

Bacon is a. perfect food. And it will boost your spirits.

wronginvestor 27分前

A final word from me today, and a test of how good AI is or isn't at predicting markets. This is what AI thinks will happen on Monday (provided Hiru doesn't release another PR Monday premarket to say payment made):

The Market Makers’ Automated Defense: Core Level 2 book holders like C

HIRU

ErnieBilco 28分前

Can anyone explain how a public company can do a direct offering on FB

https://invest.americanrebelbeer.com/?fbclid=IwY2xjawSQX4ZleHRuA2FlbQIxMABicmlkETFxZGpxOFA5OTFGUXhQUjVNc3J0YwZhcHBfaWQQMjIyMDM5MTc4ODIwMDg5MgABHhU5XXZmWscUL2ePPeDxl2deQrX_89cwsDze0N_sn4Riwg57FdElgBsX-5A4_aem_MN1M6k

AREB

Drugdoctor 28分前

You said it, not me. re"So are you claiming lightning will strike here and George and insiders are setting up investors so they(George and other insiders) can make $100 million also?"

WNFTD

suzuki1a 30分前

There’s no education involved, it’s just more guessing based on hallucinations!

RKT

i_like_bb_stock 31分前

Added more today these whack tards are stupid

LBRG

Biowatch 31分前

Diabetes researchers ejected from_conference_after criticizing White House

https://www.washingtonpost.com/health/2026/06/05/diabetes-researchers-ousted-conference-after-criticizing-trump/

The scientists, including the editor of a leading journal, were handing out copie

Diogenes of Sinope 33分前

https://investorshub.advfn.com/stock-market/AMEX/b2gold-BTG/stock-news/98687570/b2gold-announces-voting-results-from-its-2026-annu

BTG

市場データ

ニュース

投資ツール

市場

発見

Hot Features

Follow Feed

ライブオプションフロー

モニター

Anebulo Pharmaceuticals Inc (ANEB)

Anebulo Pharmaceuticals Inc (ANEB) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

主要統計と詳細

ANEB 最新ニュース

Form 15-12G - Securities registration termination [Section 12(g)]

Form 25 - Notification of the removal from listing and registration of matured, redeemed or retired securities

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Anebulo Pharmaceuticals Reports Second Quarter Fiscal Year 2026 Financial Results and Recent Updates

Form 8-K - Current report

Anebulo Pharmaceuticals Announces Intention to Voluntarily Delist from Nasdaq and Deregister with SEC

Form SC TO-I/A - Tender offer statement by Issuer: [Amend]

Form 8-K - Current report

Anebulo Pharmaceuticals Announces Final Results of Tender Offer

Form 15-12G - Securities registration termination [Section 12(g)]

Form 25 - Notification of the removal from listing and registration of matured, redeemed or retired securities

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Anebulo Pharmaceuticals Reports Second Quarter Fiscal Year 2026 Financial Results and Recent Updates

Form 8-K - Current report

Anebulo Pharmaceuticals Announces Intention to Voluntarily Delist from Nasdaq and Deregister with SEC

Form SC TO-I/A - Tender offer statement by Issuer: [Amend]

ANEB - Frequently Asked Questions (FAQ)

ANEB 取引

議論

最近閲覧した銘柄

会社情報

ビジネス

人気

アプリを入手

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

市場データ

ニュース

投資ツール

市場

発見

Hot Features

Follow Feed

ライブオプションフロー

モニター

Anebulo Pharmaceuticals Inc (ANEB)

Anebulo Pharmaceuticals Inc (ANEB) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

主要統計と詳細

ANEB 最新ニュース

Form 15-12G - Securities registration termination [Section 12(g)]

Form 25 - Notification of the removal from listing and registration of matured, redeemed or retired securities

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Anebulo Pharmaceuticals Reports Second Quarter Fiscal Year 2026 Financial Results and Recent Updates

Form 8-K - Current report

Anebulo Pharmaceuticals Announces Intention to Voluntarily Delist from Nasdaq and Deregister with SEC

Form SC TO-I/A - Tender offer statement by Issuer: [Amend]

Form 8-K - Current report

Anebulo Pharmaceuticals Announces Final Results of Tender Offer

Form 15-12G - Securities registration termination [Section 12(g)]

Form 25 - Notification of the removal from listing and registration of matured, redeemed or retired securities

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Anebulo Pharmaceuticals Reports Second Quarter Fiscal Year 2026 Financial Results and Recent Updates

Form 8-K - Current report

Anebulo Pharmaceuticals Announces Intention to Voluntarily Delist from Nasdaq and Deregister with SEC

Form SC TO-I/A - Tender offer statement by Issuer: [Amend]

ANEB - Frequently Asked Questions (FAQ)

ANEB 取引

議論

最近閲覧した銘柄

会社情報

ビジネス

人気

アプリを入手

無料で登録してください:

広告を削除する

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS